Werewolf Therapeutics Inc... (HOWL)
NASDAQ: HOWL
· Real-Time Price · USD
1.33
0.01 (0.76%)
At close: Aug 15, 2025, 3:59 PM
1.35
1.50%
After-hours: Aug 15, 2025, 05:47 PM EDT
Werewolf Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | -49K | n/a | 1.14M | 742K | 1.5M | 5.9M | 8.08M | 4.46M | 7.28M | 4.97M | 4.15M | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | 426K | 918K | 454K | 454K | 464K | 460K | 445K | 773K | n/a | 558K | 708K | 13.89M | 481K | 59K | 239K | 232K | 205K |
Gross Profit | n/a | -426K | -967K | -454K | 689K | 278K | 1.04M | 5.45M | 7.31M | 4.46M | 6.72M | 4.26M | -9.74M | -481K | -59K | -239K | -232K | -205K |
Operating Income | n/a | -17.99M | -20.35M | -17.12M | -18.96M | -17.16M | -12.96M | -9.25M | -6.07M | -12.22M | -13.18M | -12.54M | -14.97M | -15.37M | -17.88M | -13.79M | -10.96M | -7.45M |
Interest Income | 850K | 997K | 1.31M | 1.6M | 1.79M | 1.97M | 2.2M | 1.87M | 1.95M | 1.52M | 1.18M | 593K | 97K | 39K | 15K | 54K | 51K | 17K |
Pretax Income | -17.98M | -18.09M | -20.4M | -16.67M | -17.25M | -16.19M | -12M | -8.29M | -5.1M | -11.98M | -11.93M | -11.94M | -14.59M | -15.34M | -17.87M | -13.76M | -10.92M | -7.43M |
Net Income | -17.98M | -18.09M | -20.4M | -16.67M | -17.25M | -16.19M | -12M | -8.29M | -5.1M | -11.98M | -10.68M | -11.35M | -14.22M | -15.32M | -17.87M | -13.76M | -10.92M | -7.43M |
Selling & General & Admin | 4.4M | 4.87M | 4.62M | 4.6M | 4.38M | 4.53M | 4.35M | 4.31M | 4.57M | 4.98M | 4.6M | 4.44M | 5.23M | 4.42M | 4.48M | 4.01M | 3.69M | 2.63M |
Research & Development | 13.14M | 13.12M | 15.73M | 12.53M | 15.27M | 12.91M | 9.65M | 10.84M | 9.58M | 11.71M | 15.86M | 13.07M | 13.89M | 10.95M | 13.4M | 9.79M | 7.26M | 4.82M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -445K | -25K | n/a | 1.25M | 3K | 281K | n/a | 15K | n/a | -16K | -16K |
Operating Expenses | 17.54M | 17.99M | 20.35M | 17.12M | 19.65M | 17.44M | 14M | 14.7M | 14.15M | 16.69M | 20.46M | 17.51M | 19.12M | 15.37M | 17.88M | 13.79M | 10.96M | 7.45M |
Interest Expense | -1.3M | 1.26M | 1.27M | 1.24M | 1.14M | 1M | 1.24M | 900K | 955K | 172K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | -454K | -464K | -460K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | n/a | 17.99M | 20.35M | 17.12M | 20.1M | 17.9M | 14.46M | 15.15M | 14.15M | 16.69M | 20.46M | 17.51M | 19.12M | 15.37M | 17.88M | 13.79M | 10.96M | 7.45M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1.25M | -596K | -378K | -23K | -48K | n/a | -51K | -33K |
Shares Outstanding (Basic) | 44.98M | 44.83M | 44.48M | 43.7M | 43.52M | 41.61M | 36.57M | 35.65M | 35.56M | 34.78M | 30.73M | 29.76M | 27.52M | 27.39M | 27.27M | 27.19M | 17.75M | 26.29M |
Shares Outstanding (Diluted) | 44.98M | 44.83M | 44.48M | 43.7M | 43.52M | 41.61M | 36.57M | 35.65M | 35.56M | 34.78M | 30.73M | 29.76M | 27.52M | 27.39M | 27.27M | 27.19M | 17.75M | 26.29M |
EPS (Basic) | -0.4 | -0.4 | -0.46 | -0.38 | -0.4 | -0.39 | -0.33 | -0.23 | -0.14 | -0.34 | -0.35 | -0.38 | -0.52 | -0.56 | -0.66 | -0.51 | -0.62 | -0.28 |
EPS (Diluted) | -0.4 | -0.4 | -0.46 | -0.38 | -0.4 | -0.39 | -0.33 | -0.23 | -0.14 | -0.34 | -0.35 | -0.38 | -0.52 | -0.56 | -0.66 | -0.51 | -0.62 | -0.28 |
EBITDA | n/a | -16.4M | -18.69M | -14.97M | -15.65M | -14.73M | -10.3M | -8.81M | -4.33M | -11.38M | -12.76M | -12.13M | -14.79M | -15.27M | -17.81M | -13.73M | -10.89M | -7.41M |
EBIT | n/a | -16.83M | -19.13M | -15.43M | -16.11M | -15.19M | -10.76M | -9.25M | -5.1M | -11.81M | -13.18M | -12.54M | -14.97M | -15.37M | -17.88M | -13.79M | -10.96M | -7.45M |
Depreciation & Amortization | n/a | 426K | 442K | 454K | 454K | 464K | 460K | 445K | 773K | 425K | 558K | 708K | 763K | 481K | 59K | 239K | 232K | 205K |